Viewing Study NCT02106858


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-02-24 @ 8:50 AM
Study NCT ID: NCT02106858
Status: COMPLETED
Last Update Posted: 2023-07-24
First Post: 2014-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Stivarga Regulatory Post-Marketing Surveillance Study in Korea
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic or … View